BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22226581)

  • 1. Personalized treatment of prostate cancer based on inherited variations of steroid pathway-related genes.
    Todenhöfer T; Schwentner C; Stenzl A
    Eur Urol; 2012 Jul; 62(1):97-9. PubMed ID: 22226581
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of germline genetic variations in hydroxysteroid (17-beta) dehydrogenases on prostate cancer outcomes after prostatectomy.
    Audet-Walsh É; Bellemare J; Lacombe L; Fradet Y; Fradet V; Douville P; Guillemette C; Lévesque É
    Eur Urol; 2012 Jul; 62(1):88-96. PubMed ID: 22209174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroid hormone metabolism and prostate cancer.
    Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the HSD17B1 gene and risk of prostate cancer.
    Kraft P; Pharoah P; Chanock SJ; Albanes D; Kolonel LN; Hayes RB; Altshuler D; Andriole G; Berg C; Boeing H; Burtt NP; Bueno-de-Mesquita B; Calle EE; Cann H; Canzian F; Chen YC; Crawford DE; Dunning AM; Feigelson HS; Freedman ML; Gaziano JM; Giovannucci E; Gonzalez CA; Haiman CA; Hallmans G; Henderson BE; Hirschhorn JN; Hunter DJ; Kaaks R; Key T; Le Marchand L; Ma J; Overvad K; Palli D; Pike MC; Riboli E; Rodriguez C; Setiawan WV; Stampfer MJ; Stram DO; Thomas G; Thun MJ; Travis R; Trichopoulou A; Virtamo J; Wacholder S
    PLoS Genet; 2005 Nov; 1(5):e68. PubMed ID: 16311626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of cell proliferation by steroids: the role of 17HSDs.
    Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Pulkka A
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):141-8. PubMed ID: 16406264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state.
    Härkönen P; Törn S; Kurkela R; Porvari K; Pulkka A; Lindfors A; Isomaa V; Vihko P
    J Clin Endocrinol Metab; 2003 Feb; 88(2):705-12. PubMed ID: 12574203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymes as modulators in malignant transformation.
    Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Li Y; Patrikainen L; Pulkka A; Soronen P; Törn S
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):277-83. PubMed ID: 15860271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate.
    Elo JP; Akinola LA; Poutanen M; Vihko P; Kyllönen AP; Lukkarinen O; Vihko R
    Int J Cancer; 1996 Mar; 66(1):37-41. PubMed ID: 8608963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men.
    Margiotti K; Kim E; Pearce CL; Spera E; Novelli G; Reichardt JK
    Prostate; 2002 Sep; 53(1):65-8. PubMed ID: 12210481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of 17beta-hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissues.
    Koh E; Noda T; Kanaya J; Namiki M
    Prostate; 2002 Oct; 53(2):154-9. PubMed ID: 12242730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-nucleotide polymorphisms in the 17beta-hydroxysteroid dehydrogenase genes might predict the risk of side-effects of estramustine phosphate sodium in prostate cancer patients.
    Suzuki M; Muto S; Hara K; Ozeki T; Yamada Y; Kadowaki T; Tomita K; Kameyama S; Kitamura T
    Int J Urol; 2005 Feb; 12(2):166-72. PubMed ID: 15733111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells.
    Castagnetta LA; Carruba G; Traina A; Granata OM; Markus M; Pavone-Macaluso M; Blomquist CH; Adamski J
    Endocrinology; 1997 Nov; 138(11):4876-82. PubMed ID: 9348218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer.
    Rasiah KK; Gardiner-Garden M; Padilla EJ; Möller G; Kench JG; Alles MC; Eggleton SA; Stricker PD; Adamski J; Sutherland RL; Henshall SM; Hayes VM
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):89-96. PubMed ID: 19100308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of steroid sulfatase expression in PC-3 human prostate cancer cells by insulin-like growth factor II.
    Sung CH; Im HJ; Park N; Kwon Y; Shin S; Ye DJ; Cho NH; Park YS; Choi HK; Kim D; Chun YJ
    Toxicol Lett; 2013 Nov; 223(2):109-15. PubMed ID: 24055520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.
    Olson SH; Bandera EV; Orlow I
    Am J Epidemiol; 2007 Feb; 165(3):235-45. PubMed ID: 17110639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model.
    Day JM; Foster PA; Tutill HJ; Schmidlin F; Sharland CM; Hargrave JD; Vicker N; Potter BV; Reed MJ; Purohit A
    Endocr Relat Cancer; 2013 Feb; 20(1):53-64. PubMed ID: 23132791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis.
    Day JM; Tutill HJ; Purohit A; Reed MJ
    Endocr Relat Cancer; 2008 Sep; 15(3):665-92. PubMed ID: 18541621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Intracrinology". Autonomy and freedom of peripheral tissues].
    Labrie F; Bélanger A; Simard J; Luu-The V; Labrie C
    Ann Endocrinol (Paris); 1995; 56(1):23-9. PubMed ID: 7747916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 17 beta-hydroxysteroid dehydrogenases.
    Mindnich R; Möller G; Adamski J
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):7-20. PubMed ID: 15130507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.